Autres langues LifeStance Health Group, Inc.

Actions

LFST

US53228F1012

Temps réel estimé Cboe BZX Autres places de cotation 18:43:09 02/05/2024			Varia. 5j.	Varia. 1 janv.
6,435 ^USD	-0,23 %		+4,30 %	-17,94 %

12/03	LifeStance Health nomme Teresa DeLuca à son conseil d'administration	CI
07/03	LIFESTANCE HEALTH GROUP, INC. : Jefferies & Co. réitère son opinion positive sur le titre	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

LifeStance Destigmatizes Mental Health in Newest "Not One Face" Campaign Featuring Photography from Leica Ambassadors	01/05
LifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024	18/04
LifeStance Appoints Dr. Teresa DeLuca to Board of Directors	12/03
LifeStance Health Appoints Teresa DeLuca to Its Board of Directors	12/03
Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFST	12/03
Lifestance Health Group Insider Sold Shares Worth $923,391, According to a Recent SEC Filing	05/03
Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFST	03/03
Sector Update: Health Care Stocks Decline Late Afternoon	28/02
Sector Update: Health Care Stocks Softer Wednesday Afternoon	28/02
LifeStance Health Q4 Loss Narrows as Revenue Increases; Shares Rise	28/02
LifeStance Health Q4 Loss Narrows as Revenue Increases; Shares Rise	28/02
LifeStance Health Group, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02
LifeStance Health Group, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2024	28/02
LifeStance Reports Fourth Quarter and Full Year 2023 Results	28/02
LifeStance Health Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFST	24/02
Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFST	16/02
Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFST	08/02
LifeStance to Host Fourth Quarter and Full Year 2023 Earnings Conference Call on February 28, 2024	07/02
Sector Update: Health Care Stocks Rise in Late Afternoon	01/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues LifeStance Health Group, Inc.

Actions

LFST

US53228F1012

Autres langues

Filtres